All Regulation articles – Page 10
-
NewsLong-anticipated plan to regulate PFAS chemicals unveiled in US
Per- and polyfluoroalkyl substances face enforceable drinking water limits and require toxicity tests by industry
-
BusinessBees face a barrage of chemical and environmental burdens
Better understanding of the combined effects of multiple stress factors could help reduce pollinator decline
-
BusinessNew antiviral impresses against Covid-19
Merck & Co and Ridgeback’s molnupiravir reduces risk of hospitalisation and death, and may work against other coronaviruses
-
NewsUK to ease restrictions on gene editing in crops and livestock
Redefinition of genetically-modified organisms could see Crispr-edited foods brought to market
-
BusinessUS judge accepts Purdue’s opioid bankruptcy settlement plan
Deal releases $4.3bn to combat addiction, but protects Sackler family from litigation
-
BusinessUS grants Pfizer’s Covid-19 vaccine full approval
WHO calls for delay to booster programmes to allow more global distribution
-
BusinessUS bans chlorpyrifos on all food crops
Environmental agency removes remaining exceptions for agricultural use of controversial insecticide
-
OpinionThe price of failure
Drug market structures and high R&D failure rates can tempt companies into bad pricing behaviour
-
BusinessBudget cuts at UK medicines regulator raise eyebrows
MHRA to cut 300 jobs amid financial pressures arising from Brexit
-
BusinessDeveloping countries sidelined in Covid-19 vaccine scramble
Lack of funds and local manufacturing capacity has prevented Covax from competing with wealthier nations’ self-interest
-
NewsEurope raises the bar for carcinogens in artificial turf pitches
Permissible limits for certain polycyclic aromatic hydrocarbons to fall 50-fold in 2022
-
BusinessFire in Russian chemical plant kills one, injures six
Government to investigate a fatal fire at military production facility in southern Russia
-
BusinessIndustry tightens emissions reduction targets
As COP26 approaches, many firms are announcing ambitious climate goals. But are they achievable?
-
BusinessNon-animal test for skin sensitisation gets OECD approval
Combination strategy developed by BASF and Givaudan is the first complete replacement for animal testing
-
BusinessSartan contaminant recall hits generics manufacturers
Three European suppliers recalling multiple batches of medicines owing to active ingredient contamination
-
BusinessAlzheimer’s antibody gets surprise US approval
Good news for industry and future drug approvals, but physicians doubt it will be effective for most patients
-
BusinessDeadly fire in Indian chemical factory
Blaze killed 18 workers, mainly women, who were trapped inside SVS Aqua Technologies plant
-
NewsEnvironment agency overturns contentious Trump-era ‘secret science’ rule
Directive finalised at the end of Trump’s presidency would have hindered use of non-public data in policymaking
-
OpinionA sustainable legacy
President of the RSC, Tom Welton, asks what kind of chemical legacy we are leaving for the future
-
BusinessStriving to bolster the antibiotic pipeline before it becomes the next crisis
It’s been almost 10 years since the world was warned of a post-antibiotic apocalypse. Katrina Megget takes a look at the initiatives trying to support antimicrobial R&D